Rashi Sandooja MD , Oksana Hamidi DO , Catherine D. Zhang MD , Prerna Dogra MD , Shobana Athimulam MD , Leili Rahimi MD , Camila Villavicencio Torres MD , Shireen R. Chacko MD , William Young MD , Irina Bancos MD, MSc
{"title":"Bilateral Adrenal Nodules Presenting With Mild Autonomous Cortisol Secretion","authors":"Rashi Sandooja MD , Oksana Hamidi DO , Catherine D. Zhang MD , Prerna Dogra MD , Shobana Athimulam MD , Leili Rahimi MD , Camila Villavicencio Torres MD , Shireen R. Chacko MD , William Young MD , Irina Bancos MD, MSc","doi":"10.1016/j.eprac.2025.06.019","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Benign adrenocortical adenomas are frequently diagnosed on cross-sectional imaging performed for unrelated reasons. Up to 15% to 20% of adrenal nodules are bilateral, representing bilateral adenomas or primary bilateral macronodular adrenal hyperplasia.</div></div><div><h3>Methods</h3><div>Mild autonomous cortisol secretion (MACS), diagnosed based on an abnormal dexamethasone suppression test, is seen in 19% to 44% of patients with adrenal adenomas. Distinguishing unilateral from bilateral MACS in patients with bilateral nodules is important to guide appropriate therapy and relies on imaging phenotype, and, in some cases, on adrenal vein sampling.</div></div><div><h3>Results</h3><div>MACS is associated with cardiovascular morbidity, poor quality of life, frailty, and increased mortality. Reversal of MACS improves these outcomes; however, management of patients with bilateral MACS is challenging. Unilateral adrenalectomy in patients with bilateral nodules and MACS may lead to permanent remission (if MACS is unilateral), temporary remission, or improvement of the degree of MACS (if MACS is bilateral). No medical therapy is currently approved for MACS.</div></div><div><h3>Conclusion</h3><div>Here, we review the presentation, diagnosis, and management of patients with bilateral adrenal nodules and MACS.</div></div>","PeriodicalId":11682,"journal":{"name":"Endocrine Practice","volume":"31 8","pages":"Pages 1071-1083"},"PeriodicalIF":3.7000,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine Practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1530891X25009346","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
Benign adrenocortical adenomas are frequently diagnosed on cross-sectional imaging performed for unrelated reasons. Up to 15% to 20% of adrenal nodules are bilateral, representing bilateral adenomas or primary bilateral macronodular adrenal hyperplasia.
Methods
Mild autonomous cortisol secretion (MACS), diagnosed based on an abnormal dexamethasone suppression test, is seen in 19% to 44% of patients with adrenal adenomas. Distinguishing unilateral from bilateral MACS in patients with bilateral nodules is important to guide appropriate therapy and relies on imaging phenotype, and, in some cases, on adrenal vein sampling.
Results
MACS is associated with cardiovascular morbidity, poor quality of life, frailty, and increased mortality. Reversal of MACS improves these outcomes; however, management of patients with bilateral MACS is challenging. Unilateral adrenalectomy in patients with bilateral nodules and MACS may lead to permanent remission (if MACS is unilateral), temporary remission, or improvement of the degree of MACS (if MACS is bilateral). No medical therapy is currently approved for MACS.
Conclusion
Here, we review the presentation, diagnosis, and management of patients with bilateral adrenal nodules and MACS.
期刊介绍:
Endocrine Practice (ISSN: 1530-891X), a peer-reviewed journal published twelve times a year, is the official journal of the American Association of Clinical Endocrinologists (AACE). The primary mission of Endocrine Practice is to enhance the health care of patients with endocrine diseases through continuing education of practicing endocrinologists.